Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617)

Gongwin Biopharm Holdings Statistics

Total Valuation

TPEX:6617 has a market cap or net worth of TWD 8.31 billion. The enterprise value is 6.61 billion.

Market Cap	8.31B
Enterprise Value	6.61B

Important Dates

The next estimated earnings date is Tuesday, May 12, 2026.

Earnings Date	May 12, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:6617 has 122.62 million shares outstanding. The number of shares has increased by 2.70% in one year.

Current Share Class	122.62M
Shares Outstanding	122.62M
Shares Change (YoY)	+2.70%
Shares Change (QoQ)	+2.02%
Owned by Insiders (%)	24.08%
Owned by Institutions (%)	0.04%
Float	55.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	228.11
PB Ratio	3.30
P/TBV Ratio	3.29
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-57.89
EV / Sales	181.27
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-48.01

Financial Position

The company has a current ratio of 10.36, with a Debt / Equity ratio of 0.05.

Current Ratio	10.36
Quick Ratio	10.25
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	-0.94
Interest Coverage	-40.17

Financial Efficiency

Return on equity (ROE) is -4.31% and return on invested capital (ROIC) is -4.41%.

Return on Equity (ROE)	-4.31%
Return on Assets (ROA)	-4.19%
Return on Invested Capital (ROIC)	-4.41%
Return on Capital Employed (ROCE)	-7.92%
Weighted Average Cost of Capital (WACC)	4.09%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.01
Inventory Turnover	4.63

Taxes

In the past 12 months, TPEX:6617 has paid 158,000 in taxes.

Income Tax	158,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.24% in the last 52 weeks. The beta is -0.03, so TPEX:6617's price volatility has been lower than the market average.

Beta (5Y)	-0.03
52-Week Price Change	-31.24%
50-Day Moving Average	77.57
200-Day Moving Average	91.31
Relative Strength Index (RSI)	32.27
Average Volume (20 Days)	278,934

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6617 had revenue of TWD 36.45 million and -114.13 million in losses. Loss per share was -0.92.

Revenue	36.45M
Gross Profit	26.09M
Operating Income	-207.29M
Pretax Income	-120.87M
Net Income	-114.13M
EBITDA	-195.57M
EBIT	-207.29M
Loss Per Share	-0.92

Balance Sheet

The company has 1.82 billion in cash and 129.74 million in debt, with a net cash position of 1.69 billion or 13.81 per share.

Cash & Cash Equivalents	1.82B
Total Debt	129.74M
Net Cash	1.69B
Net Cash Per Share	13.81
Equity (Book Value)	2.52B
Book Value Per Share	20.23
Working Capital	1.69B

Cash Flow

In the last 12 months, operating cash flow was -135.75 million and capital expenditures -1.86 million, giving a free cash flow of -137.62 million.

Operating Cash Flow	-135.75M
Capital Expenditures	-1.86M
Depreciation & Amortization	11.72M
Net Borrowing	2.95M
Free Cash Flow	-137.62M
FCF Per Share	-1.12

Margins

Gross Margin	71.58%
Operating Margin	-568.76%
Pretax Margin	-331.64%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPEX:6617 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.70%
Shareholder Yield	-2.70%
Earnings Yield	-1.37%
FCF Yield	-1.66%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:6617 has an Altman Z-Score of 26.02 and a Piotroski F-Score of 1.

Altman Z-Score	26.02
Piotroski F-Score	1